• Staff

    MOMA group 2018

  • building

    Modern and spacious laboratories

  • Blood Samples

    Processing of blood samples

  • entrance
  • robot

    Robots automate workflows

  • 3130

    Loading samples for DNA sequencing

  • polymer
  • diagnostics

    DNA Diagnostics

  • miseq

    Genetic Diagnostics by NGS

  • genelist

    Molecular Diagnostics Gene Panels

  • robot NGS

    Robot automates NGS workflow 

  • bioinf

    Bioinformatic data analysis

  • cellline

    Our cell lines are STR-profiled

  • NGS Core Center

    NGS Core Center since 2012

  • ihc
  • ihc slice

    Immunohistochemistry detects proteins in tissue

  • Identicell

    STR-profiling of cell lines

  • cell culture

    Cell culture

  • cancer cells

    Colon adenocarcinoma cells

  • fluomic

    Fluorescence microscopy

  • samples

    Traceability is important for quality assurance

  • MOMA2009

We offer two large gene panels sequenced by targeted NGS - MOMA Hereditary Cancer Panel v3 and MOMA Heart Panel v4.
The third gene panel Thoracic aorta dilation is ordered and analyzed seperately from the MOMA Heart Panel.

A number of gene subpanels for either cancer or heart are grouped by syndromes or disease and listed below.
Subpanels can be ordered alone or in combination. Subsequent ordering of subpanels (without sending a new blood sample) is possible at a fixed fee.

For more information in Danish, please refer to the website of the Department of Molecular Medicine at Aarhus University Hospital.

MOMA Hereditary Cancer Panel v3

106 genes, 2017-01-01, targeted NGS

Gene list MOMA Cancerpanel v3 
(updated 2019-07-01)

MOMA Heart Panel v4 

102 genes, 2018-08-15, targeted NGS

Gene list MOMA Heart Panel v4

Panel Thoracic Aorta Dilation v4

27 genes, 2018-08-15

Gene list MOMA Thoracic Aorta Dilation v4

 

Current Research Networks and Large Projects

UTILITY - Using liquid tumor biopsies & genetic testing to guide personalized treatment of advanced prostate cancer: From discovery to clinical care. (2020-)

TOMBOLA - Treatment of Metastatic Bladder cancer at the time of biochemical reLApse following radicial cystectomy (2020-)

DCCC ctDNA Research Center - Danish National Center for Circulating Tumor DNA Guided cancer Treatment (2020-)

DCCC Danish circulating tumor DNA network (DCCC ctDNA) (2019-)

NorDCaP - Nordic Implementation of Personalised Prostate Cancer Diagnostics (2019-)

PRIMA - Early and accurate detection of prostate cancer in general practice (2018-)

IMPROVE - Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)

IMPROVE-IT - Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)

IMPROVE-IT2 - Implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2 (2018-2025)

"Individualized monitoring of cancer by deep sequencing of circulating tumor DNA in patients with advanced bladder cancer "(2017-)

PROCARIS - A new strategy to prevent overdiagnosis and overtreatment of non-aggressive prostate cancer in the aging male population (2016-)

PAGER - Analyzis of personal genomic rearrangements for surveillance of patients with bladder cancer (2013-)

OPRA - Oncology Precision Medicine Project Aarhus (2017-)

NEXT - Danish study of personalised cancer therapy based on tumor genetics (2017-)

""Early detection of recurrence and more curative therapy for colon cancer patients" (2016-2020)

PanCancer Analysis of Whole Genomes (PCAWG) Project (2015-)

Long non-coding RNAs as biomarkers and novel drivers of human bladder cancer (2014-)

Research Groups at MOMA

Bladder Cancer Group (Lars Dyrskjøt)

Colon Cancer Group (Claus Lindbjerg)

Prostate Cancer Group (Karina Dalsgaard Sørensen)

Medical Research Group (Claus Gravholt)

Bioinformatics Groups: